Drug Companies: Eli Lilly & Co.’s second-quarter...

Drug Companies: Eli Lilly & Co.’s second-quarter net income rose 26% to $274 million. Sales were $1.23 billion, an increase of 24%. The Indianapolis-based company attributed the growth to increased sales in international and domestic markets and a strong performance by its medical instruments division. Pfizer Inc. said second-quarter net income rose 11% to $151.2 million on a revenue increase of 15% to $1.5 billion. The company noted gains in its health-care (26%) and specialty chemicals (4%) units, but said animal health-care product sales were flat, consumer product sales declined 2% and specialty minerals sales were off 20%. Upjohn Co. said its second-quarter earnings from continuing operations jumped 21% to $114 million. Sales rose 11% to $804.7 million. The Kalamazoo, Mich.-based firm attributed its performance to a significant pension credit, strong sales and cost-control measures.